FATE vs PG · rev $13.6M vs P/E 25, rev $84.28B
Fate Therapeutics Inc (FATE) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported FATE revenue for 2024-12-31 was $13.6M. Net income was -$186.3M. Revenue was down 78.5% from 2023-12-31 to 2024-12-31. FATE currently screens at market cap $331.0M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
FATE currently screens at market cap $331.0M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the FATE and PG stock pages for the full models.
Not investment advice.